MONECO Advisors’s Boston Scientific BSX Stock Holding History

MONECO Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$245K	Sell	3,909 -883	-18%	-$70.6K	0.02%	452
2025 Q4	$457K	Sell	4,792 -57	-1%	-$5.59K	0.04%	315
2025 Q3	$473K	Buy	4,849 +1,079	+29%	+$112K	0.04%	315
2025 Q2	$405K	Sell	3,770 -272	-7%	-$27.5K	0.04%	333
2025 Q1	$408K	Sell	4,042 -323	-7%	-$32.5K	0.04%	313
2024 Q4	$390K	Buy	4,365 +504	+13%	+$44.4K	0.04%	325
2024 Q3	$324K	Buy	3,861 +272	+8%	+$21.4K	0.04%	328
2024 Q2	$276K	Buy	3,589 +106	+3%	+$7.76K	0.04%	337
2024 Q1	$239K	Sell	3,483 -438	-11%	-$28.2K	0.04%	362
2023 Q4	$227K	Buy	3,921 +17	+0.4%	+$907	0.04%	341
2023 Q3	$206K	Buy	+3,904	New	+$205K	0.06%	320

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MONECO Advisors's BSX Position: Q1 2026 in Review

MONECO Advisors reduced its Boston Scientific (BSX) stake by 18% in Q1 2026, selling an estimated $70.6K and leaving 3,909 shares worth $245K. The position accounts for 0.02% of the portfolio, ranked #452.

MONECO Advisors first reported a position in BSX in Q3 2023 and has held it in 11 quarters since. The position peaked at $473K in Q3 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

MONECO Advisors held 3,909 shares of Boston Scientific worth $245K as of Q1 2026.
MONECO Advisors sold 883 Boston Scientific shares in Q1 2026, an estimated $70.6K.
Boston Scientific made up 0.02% of MONECO Advisors's portfolio in Q1 2026, its #452 holding.
MONECO Advisors first reported a position in Boston Scientific in Q3 2023 and has held it in 11 quarters since.
MONECO Advisors's Boston Scientific position peaked at $473K in Q3 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on MONECO Advisors's 13F filing for Q1 2026, filed 8 May 2026.